Acryloyl chloride → HCID 86720314, compound
Reaction equation
[NH2:1][C:2]1[C:3]2[N:4]([C:8]([C@@H:28]3[CH2:33][CH2:32][CH2:31][CH2:30][NH:29]3)=[N:9][C:10]=2[C:11]2[CH:27]=[CH:26][C:14]([C:15]([NH:17][C:18]3[CH:23]=[C:22]([C:24]#[N:25])[CH:21]=[CH:20][N:19]=3)=[O:16])=[CH:13][CH:12]=2)[CH:5]=[CH:6][N:7]=1.[C:34](Cl)(=[O:37])[CH:35]=[CH2:36]>>[C:34]([N:29]1[CH2:30][CH2:31][CH2:32][CH2:33][C@H:28]1[C:8]1[N:4]2[CH:5]=[CH:6][N:7]=[C:2]([NH2:1])[C:3]2=[C:10]([C:11]2[CH:12]=[CH:13][C:14]([C:15]([NH:17][C:18]3[CH:23]=[C:22]([C:24]#[N:25])[CH:21]=[CH:20][N:19]=3)=[O:16])=[CH:26][CH:27]=2)[N:9]=1)(=[O:37])[CH:35]=[CH2:36]Participants
3
Procedure
This compound was prepared, in an analogous manner as described in Example 1, from (S)-4-(8-amino-3-(piperidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(4-cyanopyridin-2-yl)benzamide (intermediate 24) and acryloylchloride, to afford the title compound (4.8 mg, 10.4%). Data: UPLC(C) Rt: 2.31 min.
Workup
- customThis compound was prepared, in an analogous manner
Sources & evidence
- ORD record
- ord-82ab9407fd944e5d88784420a725eb82
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09290504B2
Reaction notes
Loading…